Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection.

Identifieur interne : 000E69 ( PubMed/Curation ); précédent : 000E68; suivant : 000E70

Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection.

Auteurs : Cathy Steel [États-Unis] ; Allison Golden [États-Unis] ; Eric Stevens [États-Unis] ; Lindsay Yokobe [États-Unis] ; Gonzalo J. Domingo [États-Unis] ; Tala De Los Santos [États-Unis] ; Thomas B. Nutman [Indonésie]

Source :

RBID : pubmed:26018537

Descripteurs français

English descriptors

Abstract

Elimination programs for Wuchereria bancrofti and Onchocerca volvulus are in critical need of sensitive, specific, and point-of-contact (POC) tools that can be used for surveillance years beyond cessation of mass drug administration when infection intensities are low. Previously, Wb123 and Ov16 were identified individually as potential filarial antigens for an antibody-based POC test. The present study compares single-antigen Wb123- and Ov16-based POC tests with an integrated configuration to detect antibodies to Wb123 and Ov16 simultaneously. Wb123 and Ov16 isolates were striped onto lateral flow strips containing anti-IgG4. Sera from W. bancrofti-, O. volvulus-, and other helminth-infected or -uninfected individuals were added to the strips with buffer. Strips were read for the appearance of a positive or negative test line for both antigens at 20 min and following drying. Sensitivity, specificity, and predictive values were calculated for the single-antigen and biplex strips. Single and biplex lateral flow strips showed nearly identical results, with >90% sensitivity for Ov16 and >92% sensitivity for Wb123. Overall specificities for the single and biplex tests were 98% and 96% for Ov16 and Wb123, respectively. Biplex tests performed as well as the single-antigen tests regardless of the intensity of patient IgG4 response. The high sensitivity and specificity make these new biplex tests extremely useful for POC long-term surveillance following mass drug administration in Africa that should reduce time and cost in areas where bancroftian filariasis and onchocerciasis are coendemic.

DOI: 10.1128/CVI.00227-15
PubMed: 26018537

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:26018537

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection.</title>
<author>
<name sortKey="Steel, Cathy" sort="Steel, Cathy" uniqKey="Steel C" first="Cathy" last="Steel">Cathy Steel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Golden, Allison" sort="Golden, Allison" uniqKey="Golden A" first="Allison" last="Golden">Allison Golden</name>
<affiliation wicri:level="1">
<nlm:affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Diagnostics Group, PATH, Seattle, Washington</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Stevens, Eric" sort="Stevens, Eric" uniqKey="Stevens E" first="Eric" last="Stevens">Eric Stevens</name>
<affiliation wicri:level="1">
<nlm:affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Diagnostics Group, PATH, Seattle, Washington</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yokobe, Lindsay" sort="Yokobe, Lindsay" uniqKey="Yokobe L" first="Lindsay" last="Yokobe">Lindsay Yokobe</name>
<affiliation wicri:level="1">
<nlm:affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Diagnostics Group, PATH, Seattle, Washington</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Domingo, Gonzalo J" sort="Domingo, Gonzalo J" uniqKey="Domingo G" first="Gonzalo J" last="Domingo">Gonzalo J. Domingo</name>
<affiliation wicri:level="1">
<nlm:affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Diagnostics Group, PATH, Seattle, Washington</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="De Los Santos, Tala" sort="De Los Santos, Tala" uniqKey="De Los Santos T" first="Tala" last="De Los Santos">Tala De Los Santos</name>
<affiliation wicri:level="1">
<nlm:affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Diagnostics Group, PATH, Seattle, Washington</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B" last="Nutman">Thomas B. Nutman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA tnutman@niaid.nih.gov.</nlm:affiliation>
<country wicri:rule="url">Indonésie</country>
<wicri:regionArea>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26018537</idno>
<idno type="pmid">26018537</idno>
<idno type="doi">10.1128/CVI.00227-15</idno>
<idno type="wicri:Area/PubMed/Corpus">000E69</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E69</idno>
<idno type="wicri:Area/PubMed/Curation">000E69</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E69</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection.</title>
<author>
<name sortKey="Steel, Cathy" sort="Steel, Cathy" uniqKey="Steel C" first="Cathy" last="Steel">Cathy Steel</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Golden, Allison" sort="Golden, Allison" uniqKey="Golden A" first="Allison" last="Golden">Allison Golden</name>
<affiliation wicri:level="1">
<nlm:affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Diagnostics Group, PATH, Seattle, Washington</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Stevens, Eric" sort="Stevens, Eric" uniqKey="Stevens E" first="Eric" last="Stevens">Eric Stevens</name>
<affiliation wicri:level="1">
<nlm:affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Diagnostics Group, PATH, Seattle, Washington</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yokobe, Lindsay" sort="Yokobe, Lindsay" uniqKey="Yokobe L" first="Lindsay" last="Yokobe">Lindsay Yokobe</name>
<affiliation wicri:level="1">
<nlm:affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Diagnostics Group, PATH, Seattle, Washington</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Domingo, Gonzalo J" sort="Domingo, Gonzalo J" uniqKey="Domingo G" first="Gonzalo J" last="Domingo">Gonzalo J. Domingo</name>
<affiliation wicri:level="1">
<nlm:affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Diagnostics Group, PATH, Seattle, Washington</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="De Los Santos, Tala" sort="De Los Santos, Tala" uniqKey="De Los Santos T" first="Tala" last="De Los Santos">Tala De Los Santos</name>
<affiliation wicri:level="1">
<nlm:affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Diagnostics Group, PATH, Seattle, Washington</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B" last="Nutman">Thomas B. Nutman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA tnutman@niaid.nih.gov.</nlm:affiliation>
<country wicri:rule="url">Indonésie</country>
<wicri:regionArea>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Clinical and vaccine immunology : CVI</title>
<idno type="eISSN">1556-679X</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Africa</term>
<term>Animals</term>
<term>Antibodies, Helminth (blood)</term>
<term>Antigens, Helminth (immunology)</term>
<term>Diagnostic Tests, Routine (methods)</term>
<term>Elephantiasis, Filarial (diagnosis)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Epidemiological Monitoring</term>
<term>Humans</term>
<term>Immunochromatography (methods)</term>
<term>Onchocerca volvulus (isolation & purification)</term>
<term>Onchocerciasis (diagnosis)</term>
<term>Onchocerciasis (epidemiology)</term>
<term>Point-of-Care Systems</term>
<term>Predictive Value of Tests</term>
<term>Sensitivity and Specificity</term>
<term>Time Factors</term>
<term>Wuchereria bancrofti (isolation & purification)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Afrique</term>
<term>Animaux</term>
<term>Anticorps antihelminthe (sang)</term>
<term>Antigènes d'helminthe (immunologie)</term>
<term>Facteurs temps</term>
<term>Filariose lymphatique (diagnostic)</term>
<term>Filariose lymphatique (épidémiologie)</term>
<term>Humains</term>
<term>Immunochromatographie ()</term>
<term>Onchocerca volvulus (isolement et purification)</term>
<term>Onchocercose (diagnostic)</term>
<term>Onchocercose (épidémiologie)</term>
<term>Sensibilité et spécificité</term>
<term>Systèmes automatisés lit malade</term>
<term>Tests diagnostiques courants ()</term>
<term>Valeur prédictive des tests</term>
<term>Wuchereria bancrofti (isolement et purification)</term>
<term>Épidémiosurveillance</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Antibodies, Helminth</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Antigens, Helminth</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Africa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Elephantiasis, Filarial</term>
<term>Onchocerciasis</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Filariose lymphatique</term>
<term>Onchocercose</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Elephantiasis, Filarial</term>
<term>Onchocerciasis</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Antigènes d'helminthe</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Onchocerca volvulus</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Onchocerca volvulus</term>
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Diagnostic Tests, Routine</term>
<term>Immunochromatography</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Anticorps antihelminthe</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Filariose lymphatique</term>
<term>Onchocercose</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Epidemiological Monitoring</term>
<term>Humans</term>
<term>Point-of-Care Systems</term>
<term>Predictive Value of Tests</term>
<term>Sensitivity and Specificity</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Afrique</term>
<term>Animaux</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Immunochromatographie</term>
<term>Sensibilité et spécificité</term>
<term>Systèmes automatisés lit malade</term>
<term>Tests diagnostiques courants</term>
<term>Valeur prédictive des tests</term>
<term>Épidémiosurveillance</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Elimination programs for Wuchereria bancrofti and Onchocerca volvulus are in critical need of sensitive, specific, and point-of-contact (POC) tools that can be used for surveillance years beyond cessation of mass drug administration when infection intensities are low. Previously, Wb123 and Ov16 were identified individually as potential filarial antigens for an antibody-based POC test. The present study compares single-antigen Wb123- and Ov16-based POC tests with an integrated configuration to detect antibodies to Wb123 and Ov16 simultaneously. Wb123 and Ov16 isolates were striped onto lateral flow strips containing anti-IgG4. Sera from W. bancrofti-, O. volvulus-, and other helminth-infected or -uninfected individuals were added to the strips with buffer. Strips were read for the appearance of a positive or negative test line for both antigens at 20 min and following drying. Sensitivity, specificity, and predictive values were calculated for the single-antigen and biplex strips. Single and biplex lateral flow strips showed nearly identical results, with >90% sensitivity for Ov16 and >92% sensitivity for Wb123. Overall specificities for the single and biplex tests were 98% and 96% for Ov16 and Wb123, respectively. Biplex tests performed as well as the single-antigen tests regardless of the intensity of patient IgG4 response. The high sensitivity and specificity make these new biplex tests extremely useful for POC long-term surveillance following mass drug administration in Africa that should reduce time and cost in areas where bancroftian filariasis and onchocerciasis are coendemic.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">26018537</PMID>
<DateCreated>
<Year>2015</Year>
<Month>07</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted>
<Year>2016</Year>
<Month>04</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1556-679X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>22</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2015</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Clinical and vaccine immunology : CVI</Title>
<ISOAbbreviation>Clin. Vaccine Immunol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection.</ArticleTitle>
<Pagination>
<MedlinePgn>896-901</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/CVI.00227-15</ELocationID>
<Abstract>
<AbstractText>Elimination programs for Wuchereria bancrofti and Onchocerca volvulus are in critical need of sensitive, specific, and point-of-contact (POC) tools that can be used for surveillance years beyond cessation of mass drug administration when infection intensities are low. Previously, Wb123 and Ov16 were identified individually as potential filarial antigens for an antibody-based POC test. The present study compares single-antigen Wb123- and Ov16-based POC tests with an integrated configuration to detect antibodies to Wb123 and Ov16 simultaneously. Wb123 and Ov16 isolates were striped onto lateral flow strips containing anti-IgG4. Sera from W. bancrofti-, O. volvulus-, and other helminth-infected or -uninfected individuals were added to the strips with buffer. Strips were read for the appearance of a positive or negative test line for both antigens at 20 min and following drying. Sensitivity, specificity, and predictive values were calculated for the single-antigen and biplex strips. Single and biplex lateral flow strips showed nearly identical results, with >90% sensitivity for Ov16 and >92% sensitivity for Wb123. Overall specificities for the single and biplex tests were 98% and 96% for Ov16 and Wb123, respectively. Biplex tests performed as well as the single-antigen tests regardless of the intensity of patient IgG4 response. The high sensitivity and specificity make these new biplex tests extremely useful for POC long-term surveillance following mass drug administration in Africa that should reduce time and cost in areas where bancroftian filariasis and onchocerciasis are coendemic.</AbstractText>
<CopyrightInformation>Copyright © 2015, American Society for Microbiology. All Rights Reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Steel</LastName>
<ForeName>Cathy</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Golden</LastName>
<ForeName>Allison</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Stevens</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yokobe</LastName>
<ForeName>Lindsay</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Domingo</LastName>
<ForeName>Gonzalo J</ForeName>
<Initials>GJ</Initials>
<AffiliationInfo>
<Affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de los Santos</LastName>
<ForeName>Tala</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Diagnostics Group, PATH, Seattle, Washington, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nutman</LastName>
<ForeName>Thomas B</ForeName>
<Initials>TB</Initials>
<AffiliationInfo>
<Affiliation>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA tnutman@niaid.nih.gov.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D023362">Evaluation Studies</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>05</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Clin Vaccine Immunol</MedlineTA>
<NlmUniqueID>101252125</NlmUniqueID>
<ISSNLinking>1556-679X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000909">Antibodies, Helminth</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000947">Antigens, Helminth</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 1991 Mar 29;251(5001):1603-5</RefSource>
<PMID Version="1">2011741</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2012;6(12):e1930</RefSource>
<PMID Version="1">23236529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 2014 Dec;91(6):1142-8</RefSource>
<PMID Version="1">25223938</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2012;6(12):e1941</RefSource>
<PMID Version="1">23236534</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2012;6(12):e1940</RefSource>
<PMID Version="1">23236533</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2000 Dec;182(6):1796-9</RefSource>
<PMID Version="1">11069258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Filaria J. 2004 Sep 3;3(1):9</RefSource>
<PMID Version="1">15347425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2006 Sep;3(9):e371</RefSource>
<PMID Version="1">17002504</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Vaccine Immunol. 2013 Aug;20(8):1155-61</RefSource>
<PMID Version="1">23740923</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 2011 Aug;85(2):229-37</RefSource>
<PMID Version="1">21813840</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2006 Mar 25;367(9515):992-9</RefSource>
<PMID Version="1">16564361</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2013;8(7):e69231</RefSource>
<PMID Version="1">23935960</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000909" MajorTopicYN="N">Antibodies, Helminth</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000947" MajorTopicYN="N">Antigens, Helminth</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003955" MajorTopicYN="N">Diagnostic Tests, Routine</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D062665" MajorTopicYN="Y">Epidemiological Monitoring</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D059665" MajorTopicYN="N">Immunochromatography</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017181" MajorTopicYN="N">Onchocerca volvulus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009855" MajorTopicYN="N">Onchocerciasis</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019095" MajorTopicYN="Y">Point-of-Care Systems</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014958" MajorTopicYN="N">Wuchereria bancrofti</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4519720</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>04</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>05</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>5</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>5</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>4</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26018537</ArticleId>
<ArticleId IdType="pii">CVI.00227-15</ArticleId>
<ArticleId IdType="doi">10.1128/CVI.00227-15</ArticleId>
<ArticleId IdType="pmc">PMC4519720</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E69 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000E69 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:26018537
   |texte=   Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:26018537" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024